Sequential changes in coagulation and platelet function following femorotibial bypass. 1984

M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan

Twenty-four patients who received no antiplatelet medications and underwent femorotibial bypass grafting (nine vein, 12 polytetrafluoroethylene [PTFE], and three composite PTFE-vein) had serial measurements taken of their platelet function and coagulation. The concentration of collagen required to produce half-maximal platelet aggregation (Kd), the platelet aggregation ratio, antithrombin III, factor VIII-related antigen, and fibrinolytic activity (platelet-rich plasma) was measured preoperatively and 3 and 7 days after surgery. Before surgery eight patients exhibited an increase of platelet reactivity to collagen. Following femorotibial bypass grafting, the mean preoperative Kd of 0.52 +/- 0.37 microgram/ml fell to 0.34 +/- 0.35 microgram/ml on the third postoperative day (P less than 0.001) and returned to 0.41 +/- 0.72 microgram/ml on day 7. Factor VIII-related antigen increased from a mean preoperative value of 248 +/- 29% of normal activity to a mean of 360 +/- 96% on postoperative day 3 (p less than 0.01) and further increased to 428 +/- 78% on day 7 (p less than 0.01). Fourteen patients had antithrombin III measurements taken, and their levels also fell on the third postoperative day (110 +/- 5.7% to 71 +/- 6.5%; p less than 0.001). No significant changes in fibrinolytic activity were noted. Persistent platelet reactivity was found in seven patients beyond the seventh postoperative day. After administration of 325 mg of aspirin, the abnormal platelet reactivity ceased. Increased platelet reactivity to collagen, factor VIII-related antigen, and a decrease in the antithrombin III level are indicative of a hypercoagulable state in these patients.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005268 Femoral Vein The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. Femoral Veins,Vein, Femoral,Veins, Femoral
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
January 1980, Canadian journal of surgery. Journal canadien de chirurgie,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
March 2011, The International journal of artificial organs,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
May 1981, Archives of surgery (Chicago, Ill. : 1960),
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
April 1966, Circulation,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
June 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
January 1975, Transfusion,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
August 1973, Archives of surgery (Chicago, Ill. : 1960),
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
July 1973, The Journal of trauma,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
October 1970, Surgery,
M D McDaniel, and W H Pearce, and J S Yao, and E C Rossi, and V A Fahey, and D Green, and W R Flinn, and J J Bergan
November 1984, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!